Results 171 to 180 of about 165,320 (303)

Implementing UK Oncology Nursing Society-Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation. [PDF]

JMIR Cancer
Mohamed Azhar MS, Ray R, Sharma S, Chauhan H, Robinson MR, Owoseni Y, Vijay A, Hussain S.   +7 more
europepmc   +1 more source

Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India. [PDF]

JCO Glob Oncol, 2021
Mallick I, Chakraborty S, Baral S, Saha S, Lal VH, Sasidharan R, Santosham RJM, Chhatbar S, Bhusal S, Goyal L, Maulik S, Phesao V, Arora S, Bhattacharyya T, Mahata A, Prasath S, Balakrishnan A, Mandal S, Arunsingh MA, Achari R, Chatterjee S.   +20 more
europepmc   +1 more source

Clinical Predictors of Response in Chronic Graft‐Versus‐Host Disease: Results From the “Predicting the Quality of Response to Specific Treatments (PQRST)” Trial

American Journal of Hematology, EarlyView.
ABSTRACT Despite significant progress in chronic GVHD therapies, challenges remain in understanding pleomorphic phenotypes and varying responses to treatment. The aim of this study was to identify predictors of treatment response. We conducted a prospective, observational cohort study of patients beginning first‐, second‐, or third‐line systemic ...
Betty K. Hamilton, Lynn Onstad, Paul A. Carpenter, Joseph Pidala, George Chen, Corey Cutler, Najla El Jurdi, Nosha Farhadfar, Mark Juckett, Carrie L. Kitko, Catherine J. Lee, Stephanie J. Lee   +11 more
wiley   +1 more source

Ethnicity and the surgical management of early invasive breast cancer in over 164 000 women

BJS (British Journal of Surgery), EarlyView., 2020
This large national study examined in detail the patterns in surgical management of early breast cancer in women of different ethnicities. Allowing for different patterns of age and stage at presentation, the surgical management of early breast cancer was similar in all women, regardless of ethnicity. All treated the same Background Limited information
T. Gathani, K. Chiuri, J. Broggio, G. Reeves, I. Barnes   +4 more
wiley   +1 more source

Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service. [PDF]

Br J Cancer
Hale J, Gilbert T, Stott M, Whelan P, Jackson R, Wong H, McKay M, Ghaneh P, Halloran C, Faluyi O, Dunne D, Neoptolemos JP, Palmer D.   +12 more
europepmc   +1 more source

Psycho-oncology service provisions for hospitalised cancer patients before and during the COVID-19 pandemic in an oncology centre in eastern India. [PDF]

Ecancermedicalscience, 2021
Mukherjee A, Chatterjee M, Chattopadhyay S, Bhowmick C, Basu A, Bhattacharjee S, Ghose S, Datta SS.   +7 more
europepmc   +1 more source

SYNERGIZING SAFETY, SAVINGS, AND PIONEERING CARE: REVOLUTIONIZING PATIENT-CENTRIC APPROACHES TO NEWLY FOOD AND DRUG ADMINISTRATION (FDA)-APPROVED CHEMOTHERAPY, IMMUNOTHERAPY, AND BIOTHERAPY (CIB) AT AN ACADEMIC MEDICAL CENTER'S INPATIENT ONCOLOGY FLOOR

Amid the ever-evolving landscape of oncology treatments provides latest FDA-approved GIBs to patients. The nursing leadership team started these patients on 1:1 nursing ratio due to the potential side-effects.
Smith, Elizabeth, Martinez, Gina, Garcia, Julio, Lykon, Jill, Trujillo, Vanessa, Alencar, Maritza   +5 more
core  

Predictors of Relapse and Post‐Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome‐Negative B‐ALL

American Journal of Hematology, EarlyView.
Sankalp Arora, Hagop Kantarjian, Koji Sasaki, Nitin Jain, Zhouxuan Li, Wei Qiao, Sanam Loghavi, Guilin Tang, Caitlin Rausch, Farhad Ravandi, Fadi G. Haddad, Jayastu Senapati, Guillermo Montalban Bravo, Alexandre Bazinet, Rita Khouri, Rebecca Garris, Guillermo Garcia‐Manero, Nicholas J. Short, Elias Jabbour   +18 more
wiley   +1 more source

Dordaviprone Maintenance After Allogeneic HCT for High‐Risk Acute Myeloid Leukemia and Myelodysplastic Neoplasm

American Journal of Hematology, EarlyView.
ABSTRACT Dordaviprone is a first‐in‐class small‐molecule imipridone. In preclinical studies, it is active against leukemia cells harboring a TP53 mutation or complex karyotype and leukemia stem cells while sparing normal bone marrow cells. This study aimed to determine the safety of dordaviprone maintenance after allogeneic hematopoietic cell ...
Vijaya Raj Bhatt, Christopher S. Wichman, Alyssa Bouska, Moataz Ellithi, Michael Haddadin, Javeed Iqbal, James E. Talmadge, Lori J. Maness, Krishna Gundabolu   +8 more
wiley   +1 more source

European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender

BJS (British Journal of Surgery), EarlyView., 2020
Recommendations for clinical and molecular identification of LS, surgical and endoscopic management of LS‐associated colorectal cancer and preventive measures for cancer were produced. The emphasis was on surgical and gastroenterological aspects of the cancer spectrum.
T. T. Seppälä, A. Latchford, I. Negoi, A. Sampaio Soares, R. Jimenez‐Rodriguez, L. Sánchez‐Guillén, D. G. Evans, N. Ryan, E. J. Crosbie, M. Dominguez‐Valentin, J. Burn, M. Kloor, M. von Knebel Doeberitz, F. J. B. van Duijnhoven, P. Quirke, J. R. Sampson, P. Møller, G. Möslein, on behalf of the European Hereditary Tumour Group (EHTG) and European Society of Coloproctology (ESCP)   +18 more
wiley   +1 more source